SCHEMBL14803886

SCHEMBL14803886

CC(C(=O)Nc1cnccc1C(C)(C)C)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.50
▸ KDM4C Q9H3R0 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ RAB9A P51151 2/20 0.45
▸ KCNQ2 O43526 1/20 0.45
▸ TRPV1 Q8NER1 1/20 0.43
▸ ELOVL1 Q9BW60 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ METAP2 P50579 1/20 0.42
▸ PSEN1 P49768 1/20 0.42
▸ PSEN2 P49810 1/20 0.42
▸ APH1B Q8WW43 1/20 0.42
▸ NCSTN Q92542 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14803776 0.85 ALDH1A1 (0.53) LMNAL3MBTL1ALDH1A1NPSR1SMN1; SMN2
SCHEMBL14818762 0.82 POLB (0.54) POLBKDM4CLMNAL3MBTL1RAB9A
SCHEMBL117772 0.75 TRPV1 (0.70) LMNAALDH1A1TRPV1MAPTHTT
SCHEMBL14803773 0.75 GAA (0.42) KDM4CALDH1A1RAB9AMAPTHTT
SCHEMBL13748300 0.71 NAMPT (0.47) POLBLMNARAB9ATRPV1
SCHEMBL111702 0.70 ROCK2 (0.73) —
SCHEMBL17365594 0.68 POLB (0.66) POLBLMNAL3MBTL1ALDH1A1MAPT
SCHEMBL7748974 0.68 POLB (0.66) POLBLMNAL3MBTL1ALDH1A1MAPT
SCHEMBL5696465 0.68 LMNA (0.60) POLBLMNAL3MBTL1ALDH1A1RAB9A
SCHEMBL12341052 0.68 MEN1 (0.42) KDM4CALDH1A1RAB9ATRPV1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169246-B2 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2015-10-27 — — US disclosed
US-20140235616-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2014-08-21 — — US disclosed
US-20130079337-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079337-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CYP11B2, COQ8A, CYP1A2 POLB 2314/4885KDM4C 3673/4885LMNA 2087/4885
US-20140235616-A1 PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CYP11B2, CYP1A2, COQ8A POLB 2065/4885KDM4C 3569/4885LMNA 2019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback